Follistatin-344
PreclinicalFollistatin-344 (FST-344)
- Category
- Growth Hormone
- Aliases
- FST-344, FS-344
- Administration
- Subcutaneous injection (preclinical/research use)
Documented benefits
Tier 1 · Peer-reviewed / regulatoryBenefit categories
Growth Hormone
Follistatin-344's defining research application, though its mechanism (myostatin blockade) is distinct from every GH-secretagogue peptide in this category.
Myostatin inhibition
Its core, defining mechanism — neutralizing myostatin and activin A to remove the body's natural limit on muscle growth.
Muscle growth
Produced some of the most dramatic muscle mass increases observed in any animal peptide study, by removing a growth-limiting signal rather than adding a growth-promoting one.